Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Fasshauer

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Cardiology|July 2, 2011
Adiponectin: sometimes good, sometimes bad?Thomas Ebert, Mathias Fasshauer
Cardiology|August 28, 2010
Does pioglitazone directly influence platelet aggregation?Thomas Ebert, Mathias Fasshauer
Current Opinion in Clinical Nutrition and Metabolic Care|April 21, 2011
Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and diseaseSusan Kralisch, Mathias Fasshauer
Atherosclerosis|February 18, 2011
Tumor necrosis factor-related apoptosis-inducing ligand and cardiovascular diseaseThomas Ebert, Mathias Fasshauer
Trends in Pharmacological Sciences|May 30, 2015
Adipokines in health and diseaseMathias Fasshauer, Matthias Blüher
BMC Medicine|November 2, 2022
Added flavors: potential contributors to body weight gain and obesity?Nathalie Judith Neumann, Mathias Fasshauer
Biochimie|December 14, 2004
Adiponectin, obesity, and cardiovascular diseaseMathias Fasshauer, Ralf Paschke, Michael Stumvoll
Clinical Endocrinology|September 29, 2011
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsiaKonstanze Miehle, Holger Stepan, Mathias Fasshauer
The Lancet. Diabetes & Endocrinology|April 16, 2014
Adipokines in gestational diabetesMathias Fasshauer, Matthias Blüher, Michael Stumvoll
Antioxidants (Basel, Switzerland)|December 19, 2020
Association of Antioxidants Use with All-Cause and Cause-Specific Mortality: A Prospective Study of the UK BiobankInken Behrendt, Gerrit Eichner, Mathias Fasshauer
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Cardiology|July 2, 2011
Adiponectin: sometimes good, sometimes bad?Thomas Ebert, Mathias Fasshauer
Cardiology|August 28, 2010
Does pioglitazone directly influence platelet aggregation?Thomas Ebert, Mathias Fasshauer
Current Opinion in Clinical Nutrition and Metabolic Care|April 21, 2011
Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and diseaseSusan Kralisch, Mathias Fasshauer
Atherosclerosis|February 18, 2011
Tumor necrosis factor-related apoptosis-inducing ligand and cardiovascular diseaseThomas Ebert, Mathias Fasshauer
Trends in Pharmacological Sciences|May 30, 2015
Adipokines in health and diseaseMathias Fasshauer, Matthias Blüher
BMC Medicine|November 2, 2022
Added flavors: potential contributors to body weight gain and obesity?Nathalie Judith Neumann, Mathias Fasshauer
Biochimie|December 14, 2004
Adiponectin, obesity, and cardiovascular diseaseMathias Fasshauer, Ralf Paschke, Michael Stumvoll
Clinical Endocrinology|September 29, 2011
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsiaKonstanze Miehle, Holger Stepan, Mathias Fasshauer
The Lancet. Diabetes & Endocrinology|April 16, 2014
Adipokines in gestational diabetesMathias Fasshauer, Matthias Blüher, Michael Stumvoll
Antioxidants (Basel, Switzerland)|December 19, 2020
Association of Antioxidants Use with All-Cause and Cause-Specific Mortality: A Prospective Study of the UK BiobankInken Behrendt, Gerrit Eichner, Mathias Fasshauer
Pageof 18